Literature summary for 3.10.1.1 extracted from

Savas, P.S.; Hemsley, K.M.; Hopwood, J.J.
Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA (2004), Mol. Genet. Metab., 82, 273-285.

Application

Application	Comment	Organism
medicine	intracerebral injection of recombinant human sulfamidase delays neuropathology in murine MPS-IIIA. Treatment reduces vacuolation and gliosis and delays the onset of ubiquitin-positive neurodegenerative changes in widespread areas of mucopolysaccharidosis type IIA brain, assessed at 24 weeks of age	Homo sapiens

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)